<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-13T15:08:50Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:11351/11395" metadataPrefix="qdc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:11351/11395</identifier><datestamp>2025-10-24T10:37:51Z</datestamp><setSpec>com_2072_378070</setSpec><setSpec>com_2072_378040</setSpec><setSpec>col_2072_378092</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>ESTRO-SIOPE guideline: Clinical management of radiotherapy in atypical teratoid/rhabdoid tumors (AT/RTs)</dc:title>
   <dc:creator>Timmermann , Beate</dc:creator>
   <dc:creator>Alapetite, Claire</dc:creator>
   <dc:creator>Dieckmann, Karin</dc:creator>
   <dc:creator>Kortmann, Rolf-Dieter</dc:creator>
   <dc:creator>Lassen-Ramshad, Yasmin</dc:creator>
   <dc:creator>Maduro, John</dc:creator>
   <dc:creator>Ramos Albiac, Monica</dc:creator>
   <dc:subject>Cervell - Càncer - Radioteràpia</dc:subject>
   <dc:subject>Sistema nerviós central - Càncer - Radioteràpia</dc:subject>
   <dc:subject>Infants</dc:subject>
   <dc:subject>DISEASES::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Complex and Mixed::Rhabdoid Tumor</dc:subject>
   <dc:subject>Other subheadings::Other subheadings::Other subheadings::/radiotherapy</dc:subject>
   <dc:subject>DISEASES::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Germ Cell and Embryonal::Teratoma</dc:subject>
   <dc:subject>DISEASES::Neoplasms::Neoplasms by Site::Nervous System Neoplasms::Central Nervous System Neoplasms::Brain Neoplasms</dc:subject>
   <dc:subject>NAMED GROUPS::Persons::Age Groups::Child</dc:subject>
   <dc:subject>ENFERMEDADES::neoplasias::neoplasias por tipo histológico::neoplasias complejas y mixtas::tumor rabdoide</dc:subject>
   <dc:subject>Otros calificadores::Otros calificadores::Otros calificadores::/radioterapia</dc:subject>
   <dc:subject>ENFERMEDADES::neoplasias::neoplasias por tipo histológico::neoplasias de células germinales y embrionarias::teratoma</dc:subject>
   <dc:subject>ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias del sistema nervioso::neoplasias del sistema nervioso central::neoplasias cerebrales</dc:subject>
   <dc:subject>DENOMINACIONES DE GRUPOS::personas::Grupos de Edad::niño</dc:subject>
   <dcterms:abstract>Atypical teratoid rhabdoid tumor; Children; Radiotherapy</dcterms:abstract>
   <dcterms:abstract>Tumor rabdoide teratoide atípic; Nens; Radioteràpia</dcterms:abstract>
   <dcterms:abstract>Tumor rabdoide teratoideo atípico; Niños; Radioterapia</dcterms:abstract>
   <dcterms:abstract>Background and purpose&#xd;
Treatment of patients with atypical teratoid/rhabdoid (AT/RT) is challenging, especially when very young (below the age of three years). Radiotherapy (RT) is part of a complex trimodality therapy. The purpose of this guideline is to provide appropriate recommendations for RT in the clinical management of patients not enrolled in clinical trials.&#xd;
Materials and methods&#xd;
Nine European experts were nominated to form a European Society for Radiotherapy and Oncology (ESTRO) guideline committee. A systematic literature search was conducted in PubMed/MEDLINE and Web of Science. They discussed and analyzed the evidence concerning the role of RT in the clinical management of AT/RT.&#xd;
Results&#xd;
Recommendations on diagnostic imaging, therapeutic principles, RT considerations regarding timing, dose, techniques, target volume definitions, dose constraints of radiation-sensitive organs at risk, concomitant chemotherapy, and follow-up were considered. Treating children with AT/RT within the framework of prospective trials or prospective registries is of utmost importance.&#xd;
Conclusion&#xd;
The present guideline summarizes the evidence and clinical-based recommendations for RT in patients with AT/RT. Prospective clinical trials and international, large registries evaluating modern treatment approaches will contribute to a better understanding of the best treatment for these children in future.</dcterms:abstract>
   <dcterms:dateAccepted>2025-10-24T10:37:51Z</dcterms:dateAccepted>
   <dcterms:available>2025-10-24T10:37:51Z</dcterms:available>
   <dcterms:created>2025-10-24T10:37:51Z</dcterms:created>
   <dcterms:issued>2024-04-30T09:59:58Z</dcterms:issued>
   <dcterms:issued>2024-04-30T09:59:58Z</dcterms:issued>
   <dcterms:issued>2024-03-14</dcterms:issued>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
   <dc:identifier>http://hdl.handle.net/11351/11395</dc:identifier>
   <dc:relation>Radiotherapy and Oncology;196</dc:relation>
   <dc:relation>https://doi.org/10.1016/j.radonc.2024.110227</dc:relation>
   <dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 International</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:publisher>Elsevier</dc:publisher>
   <dc:source>Scientia</dc:source>
</qdc:qualifieddc></metadata></record></GetRecord></OAI-PMH>